том 59 страницы 128550

Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives

Koki KATOH 1
Noriki Kutsumura 1, 2
Naoshi Yamamoto 2
Yasuyuki Nagumo 2
Tsuyoshi Saitoh 2
Yukiko Ishikawa 2
Yoko Irukayama-Tomobe 2
Ryuji Tanimura 3
Masashi Yanagisawa 2, 4, 5
Tsuyoshi Saitoh 1, 2
Тип публикацииJournal Article
Дата публикации2022-03-01
scimago Q2
wos Q2
БС2
SJR0.472
CiteScore5.1
Impact factor2.2
ISSN0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Краткое описание
The five-membered D-ring nalfurafine (d-nor-nalfurafine) derivatives with a 16-sulfonamide group were synthesized. Conversion of the 16-cyclopropylmethyl group to the 16-benzenesulfonamide group in the d-nor-nalfurafine derivatives drastically improved the orexin 1 receptor (OX1R) antagonist activities. The intramolecular hydrogen bond between the 14-hydroxy and the 16-sulfonamide groups may play an important role in increasing the probability that the 6-amide group would be located at the lower side of the C-ring, leading to an active conformation for OX1R. The assay results and the conformational analyses of the 14-OH, 14-H, and 14-dehydrated d-nor-nalfurafine derivatives suggested that the 14- and 16-substituents of the d-nor-nalfurafine derivatives had a greater effect on the affinities for the OX1R than did the 14- and 17-substituents of nalfurafine derivatives.
Найдено 
Найдено 

Топ-30

Журналы

1
Nature and Science of Sleep
1 публикация, 20%
Journal of the Electrochemical Society
1 публикация, 20%
Medicinal Research Reviews
1 публикация, 20%
Chemometrics and Intelligent Laboratory Systems
1 публикация, 20%
Synlett
1 публикация, 20%
1

Издатели

1
Taylor & Francis
1 публикация, 20%
The Electrochemical Society
1 публикация, 20%
Wiley
1 публикация, 20%
Elsevier
1 публикация, 20%
Georg Thieme Verlag KG
1 публикация, 20%
1
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
5
Поделиться
Цитировать
ГОСТ |
Цитировать
KATOH K. et al. Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives // Bioorganic and Medicinal Chemistry Letters. 2022. Vol. 59. p. 128550.
ГОСТ со всеми авторами (до 50) Скопировать
KATOH K., Kutsumura N., Yamamoto N., Nagumo Y., Saitoh T., Ishikawa Y., Irukayama-Tomobe Y., Tanimura R., Yanagisawa M., Saitoh T. Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives // Bioorganic and Medicinal Chemistry Letters. 2022. Vol. 59. p. 128550.
RIS |
Цитировать
TY - JOUR
DO - 10.1016/j.bmcl.2022.128550
UR - https://doi.org/10.1016/j.bmcl.2022.128550
TI - Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives
T2 - Bioorganic and Medicinal Chemistry Letters
AU - KATOH, Koki
AU - Kutsumura, Noriki
AU - Yamamoto, Naoshi
AU - Nagumo, Yasuyuki
AU - Saitoh, Tsuyoshi
AU - Ishikawa, Yukiko
AU - Irukayama-Tomobe, Yoko
AU - Tanimura, Ryuji
AU - Yanagisawa, Masashi
AU - Saitoh, Tsuyoshi
PY - 2022
DA - 2022/03/01
PB - Elsevier
SP - 128550
VL - 59
PMID - 35041942
SN - 0960-894X
SN - 1464-3405
ER -
BibTex
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2022_KATOH,
author = {Koki KATOH and Noriki Kutsumura and Naoshi Yamamoto and Yasuyuki Nagumo and Tsuyoshi Saitoh and Yukiko Ishikawa and Yoko Irukayama-Tomobe and Ryuji Tanimura and Masashi Yanagisawa and Tsuyoshi Saitoh},
title = {Essential structure of orexin 1 receptor antagonist YNT-707: Conversion of the 16-cyclopropylmethyl group to the 16-sulfonamide group in d-nor-nalfurafine derivatives},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2022},
volume = {59},
publisher = {Elsevier},
month = {mar},
url = {https://doi.org/10.1016/j.bmcl.2022.128550},
pages = {128550},
doi = {10.1016/j.bmcl.2022.128550}
}